Viewing Study NCT04612894


Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2025-12-27 @ 11:19 PM
Study NCT ID: NCT04612894
Status: UNKNOWN
Last Update Posted: 2020-11-03
First Post: 2020-10-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module